Patient Stories

Interview with Dr. Lucas C. Duits: Standardizing Patient Management with TissueCypher

This study evaluated the impact that variability in pathologic diagnosis has on patient care and shows that adding guidance from TissueCypher to the standard of care can improve the consistency of management and increase the percentage of progressors that receive appropriate treatment while reducing the number of non-progressors that are over treated.

Barrett's Esophagus TissueCypher

Watch Story

Interview with Dr. Raman Muthusamy: Barrett's Conundrum

Speaking with Dr. Raman Muthusamy (Clinical Professor of Medicine, UCLA) on the challenge of risk-stratifying Barrett's esophagus patients so we can focus our effective treatments on high-risk patients and avoid overtreatment of low-risk patients.

Barrett's Esophagus TissueCypher

Watch Story

Interview with Dr. Sri Komanduri, re: the 2022 AGA Clinical Practice Update

Castle Biosciences sat down with Dr. Sri Komanduri, Associate Chief of Gastroenterology and Hepatology at Northwestern Medicine, to discuss the American Gastroenterological Association (AGA) Clinical Practice Update, published July 01, 2022.

Barrett's Esophagus TissueCypher

Watch Story

Molecular Prognostic Tests are Changing Management of Dermatologic Cancers

Learn more about how Gene Expression Profiling (GEP) can be used to individualize patient care and management of melanoma.

DecisionDx-Melanoma

Watch Story

More Accurately Predicting Individual Risk of Recurrence or Metastasis

DecisionDx- Melanoma can be used to determine what level of follow-up, imaging, and referrals are appropriate for individual patients.

DecisionDx-Melanoma

Watch Story

Jerry W. – A Second Chance for Jerry

He just knew he was going to die. In September 2009, Jerry W., a retired GM employee, was diagnosed with uveal melanoma. His entire world collapsed.

Uveal Melanoma DecisionDx-UM

Peter L. – The Test of Time

It was just two days before the radiation treatment of his uveal melanoma, or eye cancer.

Uveal Melanoma DecisionDx-UM

Mary D. – Taking Matters Into Her Own Hands

Mary sat in disbelief. How could that small dot in her eye, the one her doctor had called a “freckle” just twelve years ago, now be a malignant tumor?

Uveal Melanoma DecisionDx-UM

Mary F. – Marking “Cancerversaries”

Since her diagnosis with uveal melanoma in September 2013, life looks very different for Mary Judy French.

Uveal Melanoma DecisionDx-UM

Test

Focus Area

Format

Evidence

FILTER BY TESTS

Interview with Dr. Lucas C. Duits: Standardizing Patient Management with TissueCypher

Interview with Dr. Raman Muthusamy: Barrett's Conundrum

Interview with Dr. Sri Komanduri, re: the 2022 AGA Clinical Practice Update

Molecular Prognostic Tests are Changing Management of Dermatologic Cancers

More Accurately Predicting Individual Risk of Recurrence or Metastasis

Jerry W. – A Second Chance for Jerry

Peter L. – The Test of Time

Mary D. – Taking Matters Into Her Own Hands

Mary F. – Marking “Cancerversaries”